sulfasalazine has been researched along with Cancer of Esophagus in 2 studies
Sulfasalazine: A drug that is used in the management of inflammatory bowel diseases. Its activity is generally considered to lie in its metabolic breakdown product, 5-aminosalicylic acid (see MESALAMINE) released in the colon. (From Martindale, The Extra Pharmacopoeia, 30th ed, p907)
sulfasalazine : An azobenzene consisting of diphenyldiazene having a carboxy substituent at the 4-position, a hydroxy substituent at the 3-position and a 2-pyridylaminosulphonyl substituent at the 4'-position.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Esophageal cancer is the eighth most common malignancy, and one of the leading causes of cancer-related deaths worldwide." | 1.35 | Targeting NF-kappaB signaling pathway suppresses tumor growth, angiogenesis, and metastasis of human esophageal cancer. ( Cheung, AL; Li, B; Li, YY; Tsao, SW, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yin, LB | 1 |
| Li, ZW | 1 |
| Wang, JL | 1 |
| Wang, L | 1 |
| Hou, L | 1 |
| Hu, SY | 1 |
| Chen, H | 1 |
| Luo, P | 1 |
| Cui, XB | 1 |
| Zhu, JL | 1 |
| Li, B | 1 |
| Li, YY | 1 |
| Tsao, SW | 1 |
| Cheung, AL | 1 |
2 other studies available for sulfasalazine and Cancer of Esophagus
| Article | Year |
|---|---|
Sulfasalazine inhibits esophageal cancer cell proliferation by mediating ferroptosis.
Topics: Cell Proliferation; Esophageal Neoplasms; Ferroptosis; Humans; Receptor Protein-Tyrosine Kinases; Su | 2023 |
Targeting NF-kappaB signaling pathway suppresses tumor growth, angiogenesis, and metastasis of human esophageal cancer.
Topics: Animals; Esophageal Neoplasms; Female; Humans; Immunohistochemistry; Mice; Mice, Inbred BALB C; Mice | 2009 |